Bengaluru, 02 September 2024: Rallis India Limited (‘Rallis’) a TATA Enterprise, a leading player in the Indian Agri inputs industry and Bio-Gene Technology Limited (‘Bio-Gene’), an Australian company developing the next generation of novel insecticides derived from nature, announce the successful completion of pilot-scale production of pre-commercial quantities of Flavocide®.
Highlights:
- Successful pilot-scale production of Flavocide® conducted by Rallis
- Demonstration that Flavocide® can be produced at a consistent quality and yield at pre- commercial scale
- Flavocide® produced by Rallis to be used in planned testing activities to advance the registration process for Flavocide
- Rallis has capacity to produce Flavocide® in sufficient quantities for future supply to Bio-Gene’s commercial licensees
Announcing the above, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said,
““With a long-standing history of agrochemicals manufacturing and strategic partnerships with global customers; Rallis is committed to supporting the development and commercialization of next-gen sustainable solutions for the Crop Protection and allied sectors. Our partnership with Bio-Gene for the successful process development and scale-up of their patented nature-identical Flavocide® insecticide is testament to that commitment. While Rallis does not expect the business to be material at this stage, we look forward to continuing to work closely with Bio-Gene to enable the successful global commercialization of Flavocide-based solutions over the next few years.”
A copy of the joint statement released is enclosed herewith.
Flavocide® is a nature-identical product based on Flavesone, a naturally occurring plant compound present in some eucalypts. Bio-Gene has developed a proprietary process to synthesise the molecule and produce it in commercial quantities. Bio-Gene owns all intellectual property created by its contractors relating to the synthesis of Flavocide®.
